Explore our validated laboratory methodologies, multi-phase clinical trial oversight, and specialized phyto-fingerprinting capabilities engineered for international regulatory compliance.
The global phytopharmaceutical and nutraceutical industries have transitioned from empirical botanical processing to strict molecular safety verification, toxicological clearance, and multi-omics standardized batch reproducibility.
Global regulatory bodies (US FDA DSHEA, EMA HMPC, and NMPA) no longer accept crude herbal equivalence. Modern ODM partners must ensure HPLC-DAD-MS and high-performance thin-layer chromatography (HPTLC) fingerprinting to eliminate adulterants, heavy metal toxicity, and batch inconsistency across seasonal harvests.
Safety clearance requires a phased toxicological continuum: transitioning from high-throughput cellular screening (cytotoxicity, ROS assay) to OECD-compliant LD50, acute, sub-chronic in vivo dosing, and GLP genotoxicity (Ames test, micronucleus assay) prior to clinical evaluation.
Buyers across North America and the EU now mandate full traceability from geo-authentic botanical origin (Daodi herb farms) to supercritical CO2 fluid extraction and sterile finished dosage packaging under closed CDMO chain of custody.
How MedGence bridges the gap between pharmaceutical rigor, brand commercial viability, and cross-border regulatory dossiers.
International clients require verified Chemistry, Manufacturing, and Controls (CMC) packages along with toxicological data dossiers ready for US NDI or EU Novel Food notifications.
Strict mutual non-disclosure (NDA) protocols that safeguard patented extraction processes, tailored bio-fraction combinations, and proprietary finished formulation know-how.
Seamless transition from initial micro-screening and in vitro proof-of-concept to metric-ton commercial extraction without chemical profile divergence or loss of thermolabile actives.
Certified absence of ethylene oxide (EtO), polycyclic aromatic hydrocarbons (PAHs), organochlorine pesticide residues, and microbial endotoxins under ISO 17025 accredited labs.
Delivering robust R&D infrastructure, extensive patent estates, and validated clinical studies for Tier-1 hospitals and multinational brands.
A closed-loop framework eliminating safety gaps from wild-collection variance to final high-speed packaging.
Phytochemical extraction combined with metabolomics target screening (alkaloids, flavonoids, polysaccharides) to identify top functional fractions while mapping toxic compound thresholds.
Standardizing active potency through systematic assessment across varied harvest elevations, microclimates, and harvest seasons to eliminate natural potency fluctuations.
Developing robust, reproducible QC identification and quantitative assay methods using HPTLC, HPLC-UV/CAD, GC, and chromatographic fingerprinting validatable across multi-site labs.
Low-temperature concentration, supercritical separation, and dynamic column chromatography designed to optimize active molecule yield while eliminating organic solvent residues.
Comprehensive in vitro target binding, organoid testing, in vivo animal models, and clinical safety monitoring (LD50, Ames, chronic 90-day repeat dose) ensuring total human tolerance.
Direct technology transfer into cGMP manufacturing lines producing standardized concentrates, powders, liposomal complexes, capsules, oral liquids, and enteric tablets.
How we ensure botanical active ingredients meet rigorous standards across key target geographies.
| Target Jurisdiction | Core Regulatory Framework | MedGence Safety & Technical Support Deliverables | Audit & Testing Safeguards |
|---|---|---|---|
| United States & Canada | US FDA 21 CFR Part 111 / Part 210/211; Health Canada NHP Regulations | Complete NDIN (New Dietary Ingredient Notification) dossier assembly, GRAS self-affirmation packages, master production records (MPR). | Third-party USP/AOAC-verified assays; heavy metal testing (ICP-MS: Pb, Cd, As, Hg < 0.1 ppm limits); micro-organism qPCR screening. |
| European Union & UK | EMA Traditional Herbal Medicinal Products Directive (THMPD); EFSA Novel Foods | HMPC monograph cross-referencing, full botanical characterization, stability studies under ICH Q1A(R2) conditions (zone II / IVb). | Aflatoxin (B1, B2, G1, G2) & Ochratoxin A assays; ethylene oxide (EO) non-detection limits; pesticide screening covering 500+ compounds. |
| Asia-Pacific & China | NMPA Chinese Pharmacopoeia (ChP); SAMR Health Food Blue Hat; TGA Australia | Hospital preparation registration data dossiers, National Traditional Chinese Medicine innovation files, TGA Listed Medicine ARTG listings. | Fingerprint consistency evaluation; chromatographic peak similarity >0.98; rigorous Daodi geo-origin authenticity verification. |
Pioneering AI molecular modeling, green bio-synthetic scaling, and targeted cellular safety delivery.
Deployment of machine-learning models predicting cellular target interactions and off-target cytochrome P450 inhibition before running in vitro assays.
Implementation of closed-loop green solvent extraction suites eliminating all toxic residual solvents from high-purity botanical alkaloid and terpene yields.
Development of lipid nanoparticle (LNP) and phytosome encapsulation to enhance poor polyphenol bioavailability while mitigating high-dose GI tract irritation.
Merging botanical extraction with precision yeast fermentation to produce rare bio-identical ginsenosides and cannabinoids with zero ecological depletion.
Our validated research, clinical study models, and manufacturing pipelines power China's most respected pharmaceutical brands.
Beijing Tongrentang
CR Sanjiu Medical
Sunflower Pharma
Livzon Pharma Group
Dihon Pharma
Golden Throat Group
Yangtzi River Pharma
Beihai Gofar
Humanwell Healthcare
SCIMYTH Pharma
Hanfang Pharma
Luoxin Pharma Group
Direct technical answers addressing toxicity clearance, validation methodology, and IP protection.
Access our verified product pathways to initiate your custom screening, preclinical validation, or pilot-scale CDMO contract today.
Connect directly with MedGence senior toxicologists, method development scientists, and CDMO project directors to schedule a customized study design or request our full analytical assay catalog.